Ikarian Capital, LLC Kala Pharmaceuticals, Inc. Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$6.24 - $9.58 $547,953 - $841,248	-87,813 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$6.28 - $8.79 $2.28 Million - $3.2 Million	-363,718 Reduced 80.55%	87,813 $594,000
Q3 2020 Nov 16, 2020	BUY	$7.5 - $11.11 $3.39 Million - $5.02 Million	451,531 New	451,531 $3.39 Million
Q2 2020 Aug 14, 2020	SELL	$8.33 - $13.79 $4.11 Million - $6.81 Million	-493,952 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$3.83 - $8.79 $2.03 Million - $4.65 Million	-529,479 Reduced 51.74%	493,952 $4.34 Million

Q4 2019 Jan 31, 2020	BUY	$3.36 - $4.81 $3.44 Million - $4.92 Million	1,023,431 New	1,023,431 $3.78 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.